175 related articles for article (PubMed ID: 11723247)
1. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.
Richard F; Barroso S; Martinez J; Labbé-Jullié C; Kitabgi P
Mol Pharmacol; 2001 Dec; 60(6):1392-8. PubMed ID: 11723247
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist.
Labbé-Jullié C; Barroso S; Nicolas-Etève D; Reversat JL; Botto JM; Mazella J; Bernassau JM; Kitabgi P
J Biol Chem; 1998 Jun; 273(26):16351-7. PubMed ID: 9632698
[TBL] [Abstract][Full Text] [Related]
3. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
4. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1.
Barroso S; Richard F; Nicolas-Ethève D; Reversat JL; Bernassau JM; Kitabgi P; Labbé-Jullié C
J Biol Chem; 2000 Jan; 275(1):328-36. PubMed ID: 10617622
[TBL] [Abstract][Full Text] [Related]
5. Regulation of DARPP-32 Thr75 phosphorylation by neurotensin in neostriatal neurons: involvement of glutamate signalling.
Matsuyama S; Fukui R; Higashi H; Nishi A
Eur J Neurosci; 2003 Sep; 18(5):1247-53. PubMed ID: 12956723
[TBL] [Abstract][Full Text] [Related]
6. In vivo investigations of neurotensin receptors in adipocytes, hepatocytes and enterocytes of rat.
Piątek J; Maćkowiak P; Krauss H; Nowak D; Bogdański P
Ann Agric Environ Med; 2011; 18(2):433-6. PubMed ID: 22216825
[TBL] [Abstract][Full Text] [Related]
7. Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells.
Yamada M; Yamada M; Lombet A; Forgez P; Rostène W
Life Sci; 1998; 62(23):PL 375-80. PubMed ID: 9627096
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.
Brun P; Mastrotto C; Beggiao E; Stefani A; Barzon L; Sturniolo GC; Palù G; Castagliuolo I
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G621-9. PubMed ID: 15764810
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of the neurotensin receptor 1 by mutation of Phe(358) in Helix seven.
Barroso S; Richard F; Nicolas-Ethève D; Kitabgi P; Labbé-Jullié C
Br J Pharmacol; 2002 Feb; 135(4):997-1002. PubMed ID: 11861328
[TBL] [Abstract][Full Text] [Related]
10. Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors.
Martin S; Botto JM; Vincent JP; Mazella J
Mol Pharmacol; 1999 Feb; 55(2):210-5. PubMed ID: 9927610
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692.
Lépée-Lorgeoux I; Betancur C; Souazé F; Rostène W; Bérod A; Pélaprat D
J Neurosci Res; 2000 May; 60(3):362-9. PubMed ID: 10797539
[TBL] [Abstract][Full Text] [Related]
12. Effect of the nonpeptide neurotensin antagonist, SR 48692, and two enantiomeric analogs, SR 48527 and SR 49711, on neurotensin binding and contractile responses in guinea pig ileum and colon.
Labbé-Jullié C; Deschaintres S; Gully D; Le Fur G; Kitabgi P
J Pharmacol Exp Ther; 1994 Oct; 271(1):267-76. PubMed ID: 7965724
[TBL] [Abstract][Full Text] [Related]
13. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain.
Li JH; Sicard F; Salam MA; Baek M; LePrince J; Vaudry H; Kim K; Kwon HB; Seong JY
J Mol Endocrinol; 2005 Jun; 34(3):793-807. PubMed ID: 15956348
[TBL] [Abstract][Full Text] [Related]
15. Intermolecular cross-talk between NTR1 and NTR2 neurotensin receptor promotes intracellular sequestration and functional inhibition of NTR1 receptors.
Hwang JR; Baek MW; Sim J; Choi HS; Han JM; Kim YL; Hwang JI; Kwon HB; Beaudet N; Sarret P; Seong JY
Biochem Biophys Res Commun; 2010 Jan; 391(1):1007-13. PubMed ID: 19968961
[TBL] [Abstract][Full Text] [Related]
16. [Establishment and application of human CHO/NTR1 system].
Zhang G; Sun T; Liu HJ; Niu GJ; Xu F
Yao Xue Xue Bao; 2014 Sep; 49(9):1273-8. PubMed ID: 25518326
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
[TBL] [Abstract][Full Text] [Related]
18. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors.
Nouel D; Faure MP; St Pierre JA; Alonso R; Quirion R; Beaudet A
J Neurosci; 1997 Mar; 17(5):1795-803. PubMed ID: 9030638
[TBL] [Abstract][Full Text] [Related]
19. Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.
Gully D; Lespy L; Canton M; Rostène W; Kitabgi P; Le Fur G; Maffrand JP
Life Sci; 1996; 58(8):665-74. PubMed ID: 8594316
[TBL] [Abstract][Full Text] [Related]
20. The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay.
Thomas JB; Navarro H; Warner KR; Gilmour B
Bioorg Med Chem Lett; 2009 Mar; 19(5):1438-41. PubMed ID: 19195889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
